-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 25, 2022, the seminar "Committed to Sealing Process, Standardizing Cryopreservation and Quality Control - CGT Summer Hangzhou Station" jointly organized by Saiqiao Bio, Lonza Longsha and Shanghai Weichi was successfully concluded
This seminar focused on fully enclosed automated processes, standardized cell cryopreservation and recovery, endotoxin and mycoplasma solutions to empower the standardized development of
Bridge Bio's Gentle Flex series fully enclosed automated cell handling system
Wang Zheng, a product application expert from Saiqiao Biology, brought you the introduction
Standard normalized cell cryopreservation and recovery protocols
Zhao Fenglan, an application technology expert from Shanghai Weichi, brought you a standard standardized cell cryopreservation and recovery plan, shared the relevant regulations and technical guidelines of cell therapy products, and at the same time, the brand side also participated in the on-site interactive Q&A session to give everyone first-hand details
For cell therapy products, the precise speed control and cooling of the cryopreservation process and the safe, standard and convenient recovery operation of the recovery link are crucial
The CBS & Stirling cryogenic storage series products and Barkey anhydrous resuscitation instrument represented by Shanghai Weichi can provide standard and standardized cell cryopreservation and recovery solutions to meet the application needs of various cutting-edge fields such as basic biological research, cell therapy, and biological sample banking, and empower the standardized development of
Safety control key in cell therapy: endotoxin & Mycoplasma solution
As the development of cellular gene therapy expands, new treatments and personalized medicine continue to emerge
Manager Zhu Cancan, an application technology expert from Lonza, introduced the manufacturing process of cell gene therapy products, the impact of endotoxins on this type of product, as well as product testing regulations and guidelines, and various factors
The Lonza Mycoplasma rapid detection method is suitable for rapid contamination detection and screening
At the seminar site, the team of Saiqiao Biology, Lonza Longsha and Shanghai Weichi gathered with the guests and demonstrated the machine operation for the experts and teachers in an all-round way, fully demonstrating the breakthrough of cutting-edge technology products and their future applications
Saiqiao Biology, Lonza Longsha and Shanghai Weichi will continue to deepen the field of cell therapy, explore new models of industry development under the new situation and new pattern, establish closer technical exchanges and collaboration, and continuously exert the innovative advantages of technology to jointly enter the new track of cell therapy!